Novo Nordisk Sues Eli Lilly Over Unfair Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly, claiming the rival drugmaker is using misleading ads to market…
-
-
The Systematic Expansion of GLP-1 Therapies in Modern Medicine: From Glycemic Control to Multi-Organ Protection
To begin with, GLP-1 drugs are fundamentally changing how we treat chronic diseases. Initially, these medicines primarily helped manage…
